Crossmark

Cyclosporine 0.1% (Ikervis®) treatment in steroid-dependent dupilumab-associated conjunctivitis

Crossref DOI link: https://doi.org/10.1016/j.oftale.2019.04.007

Published Print: 2019-08

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Roca-Ginés, J.

Rahhal-Ortuño, M.

Torres-Navarro, I.

Rodríguez-Serna, M.

Navarro-Mira, M.Á.
License Information

Text and Data Mining valid from 2019-08-01
More Information

This article is maintained by: Elsevier

Article Title: Cyclosporine 0.1% (Ikervis®) treatment in steroid-dependent dupilumab-associated conjunctivitis

Journal Title: Archivos de la Sociedad Española de Oftalmología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.oftale.2019.04.007

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.oftal.2019.04.013

Content Type: article

Copyright: © 2019 Sociedad Española de Oftalmología. Published by Elsevier España, S.L.U. All rights reserved.